| Literature DB >> 16100570 |
Sean M O'Donnell1, Mark W Hansberger, Jodi L Connolly, James D Chappell, Melissa J Watson, Janene M Pierce, J Denise Wetzel, Wei Han, Erik S Barton, J Craig Forrest, Tibor Valyi-Nagy, Fiona E Yull, Timothy S Blackwell, Jeffrey N Rottman, Barbara Sherry, Terence S Dermody.
Abstract
Reovirus induces apoptosis in cultured cells and in vivo. In cell culture models, apoptosis is contingent upon a mechanism involving reovirus-induced activation of transcription factor NF-kappaB complexes containing p50 and p65/RelA subunits. To explore the in vivo role of NF-kappaB in this process, we tested the capacity of reovirus to induce apoptosis in mice lacking a functional nfkb1/p50 gene. The genetic defect had no apparent effect on reovirus replication in the intestine or dissemination to secondary sites of infection. In comparison to what was observed in wild-type controls, apoptosis was significantly diminished in the CNS of p50-null mice following reovirus infection. In sharp contrast, the loss of p50 was associated with massive reovirus-induced apoptosis and uncontrolled reovirus replication in the heart. Levels of IFN-beta mRNA were markedly increased in the hearts of wild-type animals but not p50-null animals infected with reovirus. Treatment of p50-null mice with IFN-beta substantially diminished reovirus replication and apoptosis, which suggests that IFN-beta induction by NF-kappaB protects against reovirus-induced myocarditis. These findings reveal an organ-specific role for NF-kappaB in the regulation of reovirus-induced apoptosis, which modulates encephalitis and myocarditis associated with reovirus infection.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16100570 PMCID: PMC1184036 DOI: 10.1172/JCI22428
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808